rxstat › Shortages › Mumps Virus Live Attenuated Measles Virus Live Attenuated Varicella-Zoster Virus Live Attenuated Rubella Virus Live Attenuated

Mumps Virus Live Attenuated Measles Virus Live Attenuated Varicella-Zoster Virus Live Attenuated Rubella Virus Live Attenuated shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Mumps Virus Live Attenuated Measles Virus Live Attenuated Varicella-Zoster Virus Live Attenuated Rubella Virus Live Attenuated is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 of 1
Reports on file
5

Reports by product

Anticipated
PRIORIX-TETRA
25118.9CCID50 1000CCID50 1995.2623PFU 1000CCID50 · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · Disruption of the manufacture of the drug.
Resolved
PRIORIX-TETRA
25118.9CCID50 1000CCID50 1000CCID50 1995.2623CCID50 · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · ended Jul 20, 2021 · Disruption of the manufacture of the drug.
Resolved
PRIORIX-TETRA
25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · ended Jul 12, 2019 · Other (Please describe in comments)
Resolved
PRIORIX-TETRA
25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · ended Jan 17, 2019 · Demand increase for the drug.
Resolved
PRIORIX-TETRA
25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · ended Aug 21, 2018 · Delay in shipping of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Mumps Virus Live Attenuated Measles Virus Live Attenuated Varicella-Zoster Virus Live Attenuated Rubella Virus Live Attenuated to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Mumps Virus Live Attenuated Measles Virus Live Attenuated Varicella-Zoster Virus Live Attenuated Rubella Virus Live Attenuated is classified under “VIRAL VACCINES” (ATC J07BD).

Recent changes

Common questions

When will Mumps Virus Live Attenuated Measles Virus Live Attenuated Varicella-Zoster Virus Live Attenuated Rubella Virus Live Attenuated be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Mumps Virus Live Attenuated Measles Virus Live Attenuated Varicella-Zoster Virus Live Attenuated Rubella Virus Live Attenuated in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (viral vaccines)

Partial shortageHepatitis B Surface Antigen1 of 8 reported products affected · est. return Aug 10, 2026Partial shortageHepatitis B Surface Antigen Hepatitis A Virus / Inactivated1 of 2 reported products affected · est. return Jun 15, 2026No current shortage*Sarscov2 S-Protein Mrna / 5'[M27 / 3'-OgpppNo current shortageChikungunya Virus Live-AttenuatedNo current shortageHaemagglutinin-Strain A Haemagglutinin-Strain A Haemagglutinin-Strain B Haemagglutinin-Strain BNo current shortageHepatitis A Virus / Inactivated

All viral vaccines shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.